Aller au contenu
Capteurs et mesuresRevue des preuves4 min read

Wearable activity trackers plus exercise advice after cardiac rehab: fitness up 1.65 mL/kg/min

Collectif éditorial MoveVitals · Study published · Reading updated

Original paper:Impact of wearable physical activity monitoring devices with exercise prescription or advice in the maintenance phase of cardiac rehabilitation: systematic review and meta-analysis. · BMC sports science, medicine & rehabilitation · 2019 · Article original ↗

À retenir

Across 9 randomised trials with 1,352 participants, people with heart disease who used a wearable tracker plus exercise advice improved cardiorespiratory fitness by a mean 1.65 mL/kg/min more than controls (95% CI 0.64-2.66). The pooled step-count result was not significant until a sensitivity analysis was run, and the review covers few, varied trials.

Study design

Revue des preuves

Reading basis

Published abstract

Reading focus

Design & applicability

Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.

Question de recherche

Heart patients need to stay active for life after formal cardiac rehabilitation ends. Wearable activity monitors are thought to help, but no review had examined them in cardiac populations. The authors asked whether wearables combined with exercise prescription or advice improve fitness, daily activity and sedentary time in the maintenance phase.

Population et méthode

Systematic review of randomised controlled trials in cardiac populations, searching relevant databases up to January 2019, followed by narrative synthesis, meta-analysis and qualitative analysis (PROSPERO CRD42019106591). 9 studies with 1,352 participants were included. Outcomes were cardiorespiratory fitness (CRF), six-minute walk distance, step count, activity intensity and sedentary time, plus dropout reasons, adverse events and psychological impact.

Résultats

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    Fitness improved more with a wearable plus exercise advice: mean difference 1.65 mL/kg/min (95% CI 0.64-2.66, p = 0.001, I2 = 0%). Six-minute walk distance did not differ significantly between groups.
  2. 2
    Step counts were higher in 70% of studies, but the pooled effect was not significant (SMD 0.45, 95% CI -0.17 to 1.07, p = 0.15, I2 = 81%). After a sensitivity analysis the effect was significant (SMD 0.78, 95% CI 0.54-1.02, p < 0.001, I2 = 0%).
  3. 3
    Three of four studies that reported intensity found more time in moderate and moderate-to-vigorous activity. There was no difference in sedentary time.
  4. 4
    Three of six studies reported psychological benefits. No cardiac adverse events related to physical activity were reported; 62% of non-cardiac adverse events were mainly musculoskeletal injuries.
  5. 5
    Reasons for dropping out included medical conditions, lack of motivation, loss of interest and technical difficulties.

Limites et incertitude

  1. 1
    Only 9 studies were included and several outcomes were reported in just a few of them, so the intensity and psychological findings rest on very small numbers.
  2. 2
    Step-count results were heterogeneous (I2 = 81%); the significant result came from a sensitivity analysis that removed studies, which is a post-hoc choice.
  3. 3
    The wearable was always combined with exercise prescription or advice, so the device's own contribution cannot be separated from the advice.
  4. 4
    This reading rests on the abstract only.

Mise en perspective

For people who have finished cardiac rehab, a wearable paired with exercise guidance was linked to better measured fitness in these trials, and no cardiac events tied to activity were reported. The abstract does not show that a device alone is enough. Anyone with heart disease should agree an activity plan and limits with their cardiac team.

Vos données

Daily step counts and active minutes on a wearable are exactly the data tracked in these trials, and many watches also estimate VO2max. Compare weeks on the same device, and treat a consistent trend in steps or estimated fitness as more informative than a single day.

Comprendre ce type de preuve

Check which designs were included, how searches and bias assessment were conducted, and the last search date. Publication date alone does not make the underlying evidence current.

Résumé structuré des auteurs English

Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.

Background

Physical activity (PA) is a component of cardiac rehabilitation (CR). However, life-long engagement in PA is required to maintain benefits gained. Wearable PA monitoring devices (WPAM) are thought to increase PA. There appear to be no reviews which investigate the effect of WPAM in cardiac populations. We firstly aimed to systematically review randomised controlled trials within the cardiac population that investigated the effect WPAM had through the maintenance phase of CR. We specifically examined the effect on cardiorespiratory fitness (CRF), amount and intensity of daily PA, and sedentary time. Secondly, we aimed to collate outcome measures reported, reasons for drop out, adverse events, and psychological impact from utilising a WPAM.

Methods

A systematic search (up to January 2019) of relevant databases was completed, followed by a narrative synthesis, meta-analysis and qualitative analysis.

Results

Nine studies involving 1,352 participants were included. CRF was improved to a greater extent in participants using WPAM with exercise prescription or advice compared with controls (MD 1.65 mL/kg/min;95% confidence interval [CI; 0.64-2.66]; p = 0.001; I^(2) = 0%). There was no significant between group difference in six-minute walk test distance. In 70% of studies, step count was greater in participants using a WPAM with exercise prescription or advice, however the overall effect was not significant (SMD 0.45;95% [CI; - 0.17-1.07] p = 0.15; I^(2) = 81%). A sensitivity analysis resulted in significantly greater step counts in participants using a WPAM with exercise prescription or advice and reduced the heterogeneity from 81 to 0% (SMD 0.78;95% [CI;0.54-1.02]; p < 0.001; I^(2) = 0%). Three out of four studies reporting on intensity, found significantly increased time spent in moderate and moderate-vigorous intensity PA. No difference between groups was found for sedentary time. Three of six studies reported improved psychological benefits.No cardiac adverse events related to physical activity were reported and 62% of non-cardiac adverse events were primarily musculoskeletal injuries. Reasons for dropping out included medical conditions, lack of motivation, loss of interest, and technical difficulties.

Conclusions

Our meta-analysis showed WPAM with exercise prescription or advice are superior to no device in improving CRF in the maintenance phase of CR and no cardiac adverse events were reported with WPAM use. Our qualitative analysis showed evidence in favour of WPAM with exercise prescription or advice for both CRF and step count. WPAM with exercise prescription or advice did not change sedentary time. Psychological health and exercise intensity may potentially be enhanced by WPAM with exercise prescription or advice, however further research would strengthen this conclusion.

Trial registration

PROSPERO Registration Number: CRD42019106591.

Sources et attribution

Impact of wearable physical activity monitoring devices with exercise prescription or advice in the maintenance phase of cardiac rehabilitation: systematic review and meta-analysis.

Hannan AL, Harders MP, Hing W, Climstein M, Coombes JS, Furness J.

BMC sports science, medicine & rehabilitation · 2019-07-30

DOI: 10.1186/s13102-019-0126-8 ↗PubMed · 31384474 ↗Europe PMC · Licence indiquée: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée

Sources vérifiées 2026-11-01

Guides pratiques

À lire ensemble

·Étude de cohorte

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

Explications approfondiesLire l’étude →
·Validation : étude/revue

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

Explications approfondiesLire l’étude →
·Synthèse de revues

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

Explications approfondiesLire l’étude →
·Validation : étude/revue

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

Explications approfondiesLire l’étude →
Capteurs et mesures →